Technologietransfer / MDCell
MDCell is a platform to perform customer services or joint projects in the area of cell and gene engineering via Sleeping Beauty transposon system in the field of engineered T cells, protein production and cell line development. The current aim of MDCell is to develop next generation tools for cell/gene therapies especially to enable advanced immunotherapies. With this aim, MDCell plans to be a spin-off company at the end of 2022. For these exciting projects, we are seeking one highly motivated postdoctoral scientist (m/f/d) experienced in the field of immunology to join us.